Biopsy Devices Market
This analysis includes a discussion of products, competitors, market forecasts, and opportunities in the global market for biopsy devices.
Visit Meddevicetracker to view the latest analysis and updates for the biopsy devices market.
Topics Covered Include:
An overview of biopsy devices, including biopsy guidance systems, needle-based biopsy products, and other biopsy devices (biopsy forceps, curettes, and shave/punch biopsy products).
Competitive analyses by product segment. • Discussion of key drivers and limiters to the biopsy devices market.
Country and region-specific insights that are shaping the biopsy devices market.
For a Detailed description and table of contents of this report please click here: https://www.reportsworldwide.com/report/biopsy-devices-market
Biopsy devices are most commonly utilized in the diagnosis of cancer. The global incidence of cancer continues to increase, driving sales of biopsy devices.
Biopsy guidance system sales are expected to account for the largest share of total market sales, while the needle-based biopsy devices segment will register the largest growth.
The market for biopsy devices is anticipated to experience healthy growth during the forecast period (2016-21), increasing to an estimated $2.3bn by 2021.
Sophisticated biopsy devices are driving market growth. Biopsy guidance systems and vacuum-assisted biopsy devices are anticipated to remain major contributors to total market growth due to these devices improving the quality of tissue samples acquired and reducing procedure times and patient complications.
The US market for biopsy devices accounted for approximately 48% of all sales, followed by the five major European markets (France, Germany, Italy, Spain, and the UK).
The strongest growth in biopsy product sales is expected to occur in the Rest of the World market segment, which is being driven by demand for more sophisticated healthcare services in emerging markets.
To Get Sample Copy of Report please visit @ https://www.reportsworldwide.com/enquiry?report_id=41346
ReportsWorldwide.com is a leading provider of global market intelligence reports and services. With research reports from top publishers, consulting and advisory firms, ReportsWorldwide.com offers instant online access to a growing database of expert insights on global industries, companies, products, geographies and trends.
Senior Vice President
101, Arch Street
Boston, MA 02110
Phone +1 (617) 398-4994
Fax +1 (617) 398-4995
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biopsy Devices Market here
News-ID: 658620 • Views: 191
More Releases from ReportsWorldwide
World Deep Brain Stimulation Market Top Segments, Key Players Revenue, Growth Ra …
The World Deep Brain Stimulation Market is estimated to represent a global market of USD 751.8 million by 2017 with growth rate of 18.2%. Deep brain stimulation (DBS) procedure is primarily used for the treatment of neuropsychiatric disorders such as mood disorder, dementia, anxiety and others. The procedure involve the use of neurotransmitter (brain pacemaker) that enables to transmit electric impulses to the specific target of brain cells. Increasing incidence
New report explores the Gene Editing Market : Ushering The Next Breakthrough in …
Boston, MA ReportsWorldwide has announced the addition of a new report title Gene Editing The Next Breakthrough in Regenerative Medicine to its growing collection of premium market research reports. Genome editing is a type of genetic engineering in which DNA is replaced, inserted or deleted in a living organism's ggenome using engineered molecular scissors. Believed to be one of the great biotechnology breakthroughs, gene editing is a powerful tool in pharmaceutical research that
Global In-Building Wireless BTSController-based Small Cells Market Analysis and …
Boston, MA ReportsWorldwide has announced the addition of a new report title Global In-Building Wireless BTSController-based Small Cells Market Analysis and Forecast, 2017-2021 to its growing collection of premium market research reports. This report covers the leading in-building wireless enterprise BTS/controller-based small cells network equipment manufacturers: • CommScope/Airvana • Comba Telecom • Ericsson • Huawei Technologies • Nokia • SpiderCloud • ZTE Corporation This report covers the global market share for 2016 shipments as well as a forecast for 2017-2021. To view a detailed description and Table of
UDAY’s Impact and Compatibility State wise indexing of Integrated Power Supply …
Boston, MA ReportsWorldwide has announced the addition of a new report title UDAY’s Impact and Compatibility State wise indexing of Integrated Power Supply Chain in India – 2017 to its growing collection of premium market research reports. UDAY scheme was touted as the next paladin to bail out the struggling Discoms, in order to turn them green in a time horizon of 3-4 years from 2015/16. Though was optional for the
More Releases for Biopsy
Liquid Biopsy Market
Liquid biopsies are non-invasive blood tests that detect tumor DNA & RNA fragments and circulating tumor cells (CTCs), which are released into the blood from the primary tumors and metastatic sites. It is a minimally invasive technology for the detection of molecular biomarkers, excluding expensive or invasive procedures. The global liquid biopsy market accounted for $634 million in 2016, and is estimated to reach
Biopsy Devices Market Overview by Breast Biopsy, Lung Biopsy, Prostate Biopsy to …
Download Free PDF Sample Papers Now at Biopsy Devices Market https://www.reportsnreports.com/contacts/requestsample.aspx?name=1159148 . Biopsy devices market report analyzes various types of biopsy devices in market and their adoption patterns. It aims at estimating market size and future growth potential of biopsy devices market for different segments such as product, guidance technique, application, end user, and region. Global biopsy devices market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East
Prostate Biopsy Forceps Market
Global Prostate Biopsy Forceps Market Status and Trend Report offers a comprehensive analysis on Prostate Biopsy Forceps industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Browse Full Report with TOC: http://orbisresearch.com/contacts/request-sample/2072536 Key questions answered by this report include: Worldwide and Regional Market Size of Prostate Biopsy Forceps 2013-2017,
Needle Biopsy Industry 2018, Market Structure - By Type Fine-Needle Aspiration B …
Needle Biopsy Market information: by type (fine-needle aspiration biopsy, core needle biopsy, vacuum-assisted biopsy, image-guided biopsy) by utility (disposable, reusable), by applications (tumor, infection, Inflammation, others) - Global Forecast till 2023. Considering all these factors the market for Needle Biopsy is expected to reach $ 677 million by the end of 2023, this market is projected to be growing at a CAGR of ~ 5.2 % during 2017-2023. KEY PLAYERS OF NEEDLE
Liquid Biopsy Market - Insights
Liquid biopsy involves testing of the blood to identify biomarkers or cancer cells in the form of cells or pieces of DNA which are separated from the tumor and are circulating in the blood. Liquid biopsy helps in early detection of cancer, which would aid in adopting an optimal treatment plan. It is a non-invasive technique, which makes frequent testing possible, and effectiveness of cancer treatment can also be validated
Liquid Biopsy Market Liquid Biopsy Technology Sales Report 2020
For Report Sample Contact: email@example.com or +91-11-47067990 Report Table of Contents 1. Introduction to Liquid Biopsy: A Non-Invasive, Game-Changer Diagnostic Tool 2. Mechanism of Action: Major Components of Liquid Biopsy 2.1 Circulating Tumor Cells 2.1.1 Parameters Guiding Circulating Cell Tumors 2.2 Circulating Tumor Nucleic Acids (ctNA) 2.2.1 Cell-Free Tumor DNA 2.2.2 Other Circulatory Tumor Nucleic Acid: microRNA, mRNA & Long Non-Coding